BSA for Pediatric Dosing: Why Formula Choice Matters More in Children

July 14, 2026

Why Pediatric BSA Deserves Its Own Guide

Body surface area formulas were each derived from specific study populations, and none of the three most common ones — Mosteller, DuBois, Haycock — were built from identical groups of subjects. For adult-sized patients, this rarely matters; the formulas agree within about 1%. For children, especially smaller or younger children, the gap between formulas widens meaningfully, which is why formula choice gets specific attention in pediatric dosing.

Why Haycock Is Often Preferred in Pediatrics

The Haycock formula — BSA = 0.024265 × height^0.3964 × weight^0.5378 — was validated across a study population that specifically included infants and children, not just adults. A study evaluating nine different BSA formulas for pediatric patients, published via the NIH’s PubMed Central archive, found that Haycock and Mosteller were among the most recommended formulas overall, with Haycock specifically noted as well-suited across the pediatric size range. This is why many pediatric oncology and dosing protocols specifically default to Haycock rather than DuBois, even though DuBois remains an accepted general-purpose formula for adults.

How Much Do the Formulas Actually Diverge in Children?

Using the same three formulas from the BSA calculator, a smaller child (150 cm, 25 kg) shows roughly a 7% spread between the highest and lowest formula result — compared to about 1% for an average adult. See BSA worked examples for the full numbers. That gap matters more in pediatric dosing because children generally have less physiological margin for a dosing error than adults, making formula selection a more consequential decision.

Why BSA Instead of Weight-Based (mg/kg) Dosing in Children?

Many pediatric medications actually use weight-based (mg/kg) dosing rather than BSA, particularly in infants and very young children where BSA formulas are less reliable. BSA-based dosing tends to be used more in specific contexts — chemotherapy protocols especially — where surface-area-based clearance modeling has stronger evidence behind it than weight alone. Which convention applies depends entirely on the specific drug and protocol; parents and caregivers should never assume one dosing method applies universally.

Newborns Are a Special Case

Very young infants and newborns fall outside the population most BSA formulas were validated against, and some pediatric literature specifically recommends alternative formulas (such as the Meban formula) for neonates rather than Mosteller, DuBois, or Haycock. This calculator’s three formulas are appropriate for general pediatric and adult use, but neonatal dosing decisions should always follow the specific formula and protocol a pediatric care team specifies.

What This Means for Parents and Caregivers

If your child’s care team references a BSA value, it’s reasonable to ask which formula they used, since that number directly determines a calculated dose. The BSA calculator is a useful reference to understand the calculation and see how the three common formulas compare for your child’s specific height and weight — but it does not replace your child’s prescribing provider’s calculation, which follows their institution’s exact protocol. See how BSA is used for chemotherapy dosing for how the mg/m² dosing convention works once a BSA value is established.